Published in Nucleic Acids Res on December 02, 2011
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2012) 8.41
The ChEMBL bioactivity database: an update. Nucleic Acids Res (2013) 5.41
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2013) 5.25
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2014) 3.55
PubChem Substance and Compound databases. Nucleic Acids Res (2015) 2.84
The Comparative Toxicogenomics Database: update 2013. Nucleic Acids Res (2012) 2.72
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2015) 2.44
DGIdb: mining the druggable genome. Nat Methods (2013) 2.26
Dark chemical matter as a promising starting point for drug lead discovery. Nat Chem Biol (2015) 2.18
PubChem BioAssay: 2014 update. Nucleic Acids Res (2013) 2.14
In silico repositioning-chemogenomics strategy identifies new drugs with potential activity against multiple life stages of Schistosoma mansoni. PLoS Negl Trop Dis (2015) 1.42
What is the likelihood of an active compound to be promiscuous? Systematic assessment of compound promiscuity on the basis of PubChem confirmatory bioassay data. AAPS J (2013) 1.35
Public domain databases for medicinal chemistry. J Med Chem (2012) 1.23
Polypharmacology: drug discovery for the future. Expert Rev Clin Pharmacol (2013) 1.18
High-resolution view of compound promiscuity. F1000Res (2013) 1.11
PubChem structure-activity relationship (SAR) clusters. J Cheminform (2015) 1.05
Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays. Nucleic Acids Res (2012) 1.00
Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways. PLoS Comput Biol (2013) 1.00
SwissSidechain: a molecular and structural database of non-natural sidechains. Nucleic Acids Res (2012) 0.99
Personal genomes, quantitative dynamic omics and personalized medicine. Quant Biol (2013) 0.98
FINDSITE(X): a structure-based, small molecule virtual screening approach with application to all identified human GPCRs. Mol Pharm (2012) 0.98
Activity, assay and target data curation and quality in the ChEMBL database. J Comput Aided Mol Des (2015) 0.97
Effects of multiple conformers per compound upon 3-D similarity search and bioassay data analysis. J Cheminform (2012) 0.95
An Overview of the Challenges in Designing, Integrating, and Delivering BARD: A Public Chemical-Biology Resource and Query Portal for Multiple Organizations, Locations, and Disciplines. J Biomol Screen (2014) 0.95
ChEMBL web services: streamlining access to drug discovery data and utilities. Nucleic Acids Res (2015) 0.94
Identification of Small-Molecule Frequent Hitters from AlphaScreen High-Throughput Screens. J Biomol Screen (2013) 0.94
Experimental validation of FINDSITE(comb) virtual ligand screening results for eight proteins yields novel nanomolar and micromolar binders. J Cheminform (2014) 0.94
Molecular graph convolutions: moving beyond fingerprints. J Comput Aided Mol Des (2016) 0.94
Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery? J Med Chem (2015) 0.93
The influence of negative training set size on machine learning-based virtual screening. J Cheminform (2014) 0.92
The influence of the inactives subset generation on the performance of machine learning methods. J Cheminform (2013) 0.91
Systematic study of mitochondrial toxicity of environmental chemicals using quantitative high throughput screening. Chem Res Toxicol (2013) 0.91
Behavioral barcoding in the cloud: embracing data-intensive digital phenotyping in neuropharmacology. Trends Biotechnol (2012) 0.90
A functional siRNA screen identifies genes modulating angiotensin II-mediated EGFR transactivation. J Cell Sci (2013) 0.88
Predicting the protein targets for athletic performance-enhancing substances. J Cheminform (2013) 0.88
Monitoring drug promiscuity over time. F1000Res (2014) 0.88
An efficient algorithm coupled with synthetic minority over-sampling technique to classify imbalanced PubChem BioAssay data. Anal Chim Acta (2013) 0.88
Prediction of human population responses to toxic compounds by a collaborative competition. Nat Biotechnol (2015) 0.88
Determining the Degree of Promiscuity of Extensively Assayed Compounds. PLoS One (2016) 0.88
FireDB: a compendium of biological and pharmacologically relevant ligands. Nucleic Acids Res (2013) 0.87
BioAssay Research Database (BARD): chemical biology and probe-development enabled by structured metadata and result types. Nucleic Acids Res (2014) 0.87
In silico methods for drug repurposing and pharmacology. Wiley Interdiscip Rev Syst Biol Med (2016) 0.85
A controlled vocabulary for pathway entities and events. Database (Oxford) (2014) 0.85
Discovering new medicines targeting helicases: challenges and recent progress. J Biomol Screen (2013) 0.85
Entering the 'big data' era in medicinal chemistry: molecular promiscuity analysis revisited. Future Sci OA (2017) 0.85
PubChem BioAssay: 2017 update. Nucleic Acids Res (2016) 0.84
Promiscuity progression of bioactive compounds over time. F1000Res (2015) 0.83
Profiling animal toxicants by automatically mining public bioassay data: a big data approach for computational toxicology. PLoS One (2014) 0.83
Inhibitors of Streptococcus pneumoniae surface endonuclease EndA discovered by high-throughput screening using a PicoGreen fluorescence assay. J Biomol Screen (2012) 0.82
Chemically Aware Model Builder (camb): an R package for property and bioactivity modelling of small molecules. J Cheminform (2015) 0.82
Drug2Gene: an exhaustive resource to explore effectively the drug-target relation network. BMC Bioinformatics (2014) 0.82
Activity cliffs in PubChem confirmatory bioassays taking inactive compounds into account. J Comput Aided Mol Des (2013) 0.82
Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP. Biochemistry (2013) 0.82
Computational tools and resources for metabolism-related property predictions. 1. Overview of publicly available (free and commercial) databases and software. Future Med Chem (2012) 0.81
Curation and analysis of multitargeting agents for polypharmacological modeling. J Chem Inf Model (2014) 0.81
Contributions of academic laboratories to the discovery and development of chemical biology tools. J Med Chem (2013) 0.81
KIDFamMap: a database of kinase-inhibitor-disease family maps for kinase inhibitor selectivity and binding mechanisms. Nucleic Acids Res (2012) 0.81
Taking Open Innovation to the Molecular Level - Strengths and Limitations. Mol Inform (2012) 0.81
Predicting Mouse Liver Microsomal Stability with "Pruned" Machine Learning Models and Public Data. Pharm Res (2015) 0.81
In silico identification and pharmacological evaluation of novel endocrine disrupting chemicals that act via the ligand-binding domain of the estrogen receptor α. Toxicol Sci (2014) 0.80
Pathway analysis for drug repositioning based on public database mining. J Chem Inf Model (2014) 0.80
ChEpiMod: a knowledgebase for chemical modulators of epigenome reader domains. Bioinformatics (2014) 0.80
WITHDRAWN-a resource for withdrawn and discontinued drugs. Nucleic Acids Res (2015) 0.80
Benchmarking methods and data sets for ligand enrichment assessment in virtual screening. Methods (2014) 0.79
Mining Chemical Activity Status from High-Throughput Screening Assays. PLoS One (2015) 0.79
Predicting drug target interactions using meta-path-based semantic network analysis. BMC Bioinformatics (2016) 0.79
Many approved drugs have bioactive analogs with different target annotations. AAPS J (2014) 0.78
Cofactor-independent phosphoglycerate mutase from nematodes has limited druggability, as revealed by two high-throughput screens. PLoS Negl Trop Dis (2014) 0.78
Plurigon: three dimensional visualization and classification of high-dimensionality data. Front Physiol (2013) 0.78
Amyloid-precursor-protein-lowering small molecules for disease modifying therapy of Alzheimer's disease. PLoS One (2013) 0.78
Patterns of metabolite changes identified from large-scale gene perturbations in Arabidopsis using a genome-scale metabolic network. Plant Physiol (2015) 0.78
Exploring compound promiscuity patterns and multi-target activity spaces. Comput Struct Biotechnol J (2014) 0.78
When drug discovery meets web search: Learning to Rank for ligand-based virtual screening. J Cheminform (2015) 0.78
An integrated network platform for contextual prioritization of drugs and pathways. Mol Biosyst (2015) 0.77
iCAGES: integrated CAncer GEnome Score for comprehensively prioritizing driver genes in personal cancer genomes. Genome Med (2016) 0.77
In vitro and in vivo activities of HPi1, a selective antimicrobial against Helicobacter pylori. Antimicrob Agents Chemother (2014) 0.77
A unified proteochemometric model for prediction of inhibition of cytochrome p450 isoforms. PLoS One (2013) 0.77
Assessing HTS performance using BioAssay Ontology: screening and analysis of a bacterial phospho-N-acetylmuramoyl-pentapeptide translocase campaign. Assay Drug Dev Technol (2014) 0.77
Global analysis reveals families of chemical motifs enriched for HERG inhibitors. PLoS One (2015) 0.77
PhIN: A Protein Pharmacology Interaction Network Database. CPT Pharmacometrics Syst Pharmacol (2015) 0.76
An integrative data analysis platform for gene set analysis and knowledge discovery in a data warehouse framework. Database (Oxford) (2016) 0.76
Cheminformatics models based on machine learning approaches for design of USP1/UAF1 abrogators as anticancer agents. Syst Synth Biol (2015) 0.76
bioassayR: Cross-Target Analysis of Small Molecule Bioactivity. J Chem Inf Model (2016) 0.76
Structure based virtual screening of novel inhibitors against multidrug resistant superbugs. Bioinformation (2012) 0.76
Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders. Schizophr Res Treatment (2016) 0.75
Web search and data mining of natural products and their bioactivities in PubChem. Sci China Chem (2013) 0.75
Reporting biological assay screening results for maximum impact. Drug Discov Today Technol (2015) 0.75
A ranking method for the concurrent learning of compounds with various activity profiles. J Cheminform (2015) 0.75
Integrating in silico resources to map a signaling network. Methods Mol Biol (2014) 0.75
Target enhanced 2D similarity search by using explicit biological activity annotations and profiles. J Cheminform (2015) 0.75
ChemTreeMap: an interactive map of biochemical similarity in molecular datasets. Bioinformatics (2016) 0.75
A detailed physiologically based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine Renin-Angiotensin-aldosterone system. Front Physiol (2013) 0.75
The Principles of Ligand Specificity on beta-2-adrenergic receptor. Sci Rep (2016) 0.75
PubChem atom environments. J Cheminform (2015) 0.75
Activity artifacts in drug discovery and different facets of compound promiscuity. F1000Res (2014) 0.75
Effective chemical constituent's identification of extracting solution from herbs - a review. Afr J Tradit Complement Altern Med (2014) 0.75
Analyzing compound activity records and promiscuity degrees in light of publication statistics. F1000Res (2016) 0.75
A chemoinformatics approach to the discovery of lead-like molecules from marine and microbial sources en route to antitumor and antibiotic drugs. Mar Drugs (2014) 0.75
Comparison of Points of Departure for Health Risk Assessment Based on High-Throughput Screening Data. Environ Health Perspect (2016) 0.75
CART-a chemical annotation retrieval toolkit. Bioinformatics (2016) 0.75
ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res (2011) 14.51
PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res (2009) 11.05
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2010) 10.97
Thousands of chemical starting points for antimalarial lead identification. Nature (2010) 8.28
Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature (2010) 5.08
An overview of the PubChem BioAssay resource. Nucleic Acids Res (2009) 4.75
FlyRNAi: the Drosophila RNAi screening center database. Nucleic Acids Res (2006) 2.43
A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta. Proc Natl Acad Sci U S A (2008) 2.39
Navigating the kinome. Nat Chem Biol (2011) 1.88
Integrated chemical genomics reveals modifiers of survival in human embryonic stem cells. Stem Cells (2009) 1.36
High-throughput screening and chemical biology: new approaches for understanding circadian clock mechanisms. Chem Biol (2009) 1.21
Pocket computer program for fitting the Hill equation. Comput Biol Med (1984) 0.99
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2005) 22.98
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2007) 22.53
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2008) 21.36
PIRSF: family classification system at the Protein Information Resource. Nucleic Acids Res (2004) 19.62
CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res (2010) 19.07
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2006) 18.85
CDD: a Conserved Domain Database for protein classification. Nucleic Acids Res (2005) 18.85
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2006) 18.84
CDD: a database of conserved domain alignments with links to domain three-dimensional structure. Nucleic Acids Res (2002) 18.54
NCBI GEO: mining millions of expression profiles--database and tools. Nucleic Acids Res (2005) 17.61
CD-Search: protein domain annotations on the fly. Nucleic Acids Res (2004) 16.76
Open mass spectrometry search algorithm. J Proteome Res (2004) 15.25
CDD: a curated Entrez database of conserved domain alignments. Nucleic Acids Res (2003) 14.38
CDART: protein homology by domain architecture. Genome Res (2002) 12.95
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2009) 12.51
The Protein Information Resource: an integrated public resource of functional annotation of proteins. Nucleic Acids Res (2002) 12.20
CDD: a conserved domain database for interactive domain family analysis. Nucleic Acids Res (2006) 11.41
The Protein Information Resource. Nucleic Acids Res (2003) 11.17
PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res (2009) 11.05
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2010) 10.97
CDD: specific functional annotation with the Conserved Domain Database. Nucleic Acids Res (2008) 10.73
Database resources of the National Center for Biotechnology Information: update. Nucleic Acids Res (2004) 9.85
Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2011) 8.62
MMDB: annotating protein sequences with Entrez's 3D-structure database. Nucleic Acids Res (2006) 7.57
CDD: conserved domains and protein three-dimensional structure. Nucleic Acids Res (2012) 6.39
MMDB: Entrez's 3D-structure database. Nucleic Acids Res (2003) 6.14
PIP(2) and proteins: interactions, organization, and information flow. Annu Rev Biophys Biomol Struct (2001) 5.66
Representative proteomes: a stable, scalable and unbiased proteome set for sequence analysis and functional annotation. PLoS One (2011) 5.64
The pediatric preclinical testing program: description of models and early testing results. Pediatr Blood Cancer (2007) 5.28
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol (2005) 5.27
The NCBI BioSystems database. Nucleic Acids Res (2009) 4.80
An overview of the PubChem BioAssay resource. Nucleic Acids Res (2009) 4.75
MMDB: Entrez's 3D-structure database. Nucleic Acids Res (2002) 4.42
Comparison of sequence and structure alignments for protein domains. Proteins (2002) 4.24
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition. Proc Natl Acad Sci U S A (2008) 4.07
Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell (2004) 3.98
The Protein Ontology: a structured representation of protein forms and complexes. Nucleic Acids Res (2010) 3.74
BioThesaurus: a web-based thesaurus of protein and gene names. Bioinformatics (2005) 3.43
PubChem as a public resource for drug discovery. Drug Discov Today (2010) 3.40
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev (2010) 3.24
Predicting protein-protein interactions based only on sequences information. Proc Natl Acad Sci U S A (2007) 3.06
Coordination of Rab8 and Rab11 in primary ciliogenesis. Proc Natl Acad Sci U S A (2010) 2.88
S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A (2007) 2.77
Electrostatic sequestration of PIP2 on phospholipid membranes by basic/aromatic regions of proteins. Biophys J (2004) 2.66
Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci U S A (2002) 2.65
Amine-controlled assembly of metal-sulfite architecture from 1D chains to 3D framework. Inorg Chem (2007) 2.57
Plasmon-controlled fluorescence: a new paradigm in fluorescence spectroscopy. Analyst (2008) 2.45
Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation. Nat Cell Biol (2010) 2.37
The yak genome and adaptation to life at high altitude. Nat Genet (2012) 2.34
Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants. PLoS Biol (2007) 2.34
Outcome of a workshop on archiving structural models of biological macromolecules. Structure (2006) 2.32
Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer (2010) 2.20
An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci U S A (2005) 2.18
Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke (2008) 2.18
PubChem BioAssay: 2014 update. Nucleic Acids Res (2013) 2.14
A QTL resource and comparison tool for pigs: PigQTLDB. Mamm Genome (2005) 2.11
14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell (2009) 2.09
MMDB: 3D structures and macromolecular interactions. Nucleic Acids Res (2011) 2.06
Exo70 interacts with phospholipids and mediates the targeting of the exocyst to the plasma membrane. EMBO J (2007) 2.03
Human epithelial cancers secrete immunoglobulin g with unidentified specificity to promote growth and survival of tumor cells. Cancer Res (2003) 2.00
Membrane association and functional regulation of Sec3 by phospholipids and Cdc42. J Cell Biol (2008) 1.99
The PubChem chemical structure sketcher. J Cheminform (2009) 1.98
DNA-nanoparticle superlattices formed from anisotropic building blocks. Nat Mater (2010) 1.92
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate (2006) 1.90
Inferred Biomolecular Interaction Server--a web server to analyze and predict protein interacting partners and binding sites. Nucleic Acids Res (2009) 1.85
Synthesis, structure, and luminescent properties of hybrid inorganic-organic framework materials formed by lead aromatic carboxylates: inorganic connectivity variation from 0D to 3D. Inorg Chem (2009) 1.85
Annotation of functional sites with the Conserved Domain Database. Database (Oxford) (2012) 1.81
LEAFY COTYLEDON1 is a key regulator of fatty acid biosynthesis in Arabidopsis. Plant Physiol (2008) 1.79
Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption. Cancer Res (2007) 1.79
MMDB and VAST+: tracking structural similarities between macromolecular complexes. Nucleic Acids Res (2013) 1.79
Autophagy is a therapeutic target in anticancer drug resistance. Biochim Biophys Acta (2010) 1.77
The role of electrostatics in protein-membrane interactions. Biochim Biophys Acta (2006) 1.76
PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib. BMC Cancer (2011) 1.73